Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-Angle Glaucoma or Ocular Hypertension”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01453855
What this trial is testing

Travoprost 3-Month Safety and Efficacy Study

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 1,099
Testing effectiveness (Phase 2)Study completedNCT02136940
What this trial is testing

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOcular HypertensionEye Disease
Amakem, NV 103
Post-approval studies (Phase 4)Study completedNCT00300079
What this trial is testing

Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Alcon Research 30
Large-scale testing (Phase 3)Study completedNCT00108017
What this trial is testing

Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)

Who this might be right for
GlaucomaOcular Hypertension
Merck Sharp & Dohme LLC 330
Large-scale testing (Phase 3)Study completedNCT00691717
What this trial is testing

Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOular Hypertension
Alcon Research 201
Large-scale testing (Phase 3)Ended earlyNCT02801617
What this trial is testing

Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Laboratorios Sophia S.A de C.V. 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT04499248
What this trial is testing

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
AbbVie 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06964191
What this trial is testing

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
PolyActiva Pty Ltd 75
Post-approval studies (Phase 4)Study completedNCT04465864
What this trial is testing

Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert

Who this might be right for
Glaucoma, Primary Open AngleCataract
Wolstan and Goldberg Eye Associates 40
Testing effectiveness (Phase 2)Study completedNCT00069719
What this trial is testing

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research
Large-scale testing (Phase 3)Study completedNCT02339584
What this trial is testing

Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 493
Early research (Phase 1)Study completedNCT04284514
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution

Who this might be right for
Ocular HypertensionPrimary Open Angle Glaucoma
Aerpio Therapeutics 91
Testing effectiveness (Phase 2)Study completedNCT00650338
What this trial is testing

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Santen Inc. 165
Testing effectiveness (Phase 2)Study completedNCT02537015
What this trial is testing

An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

Who this might be right for
Primary Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 81
Large-scale testing (Phase 3)Study completedNCT02617459
What this trial is testing

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-angle GlaucomaOcular Hypertension
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 366
Testing effectiveness (Phase 2)Study completedNCT00651859
What this trial is testing

Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
Allergan 111
Large-scale testing (Phase 3)Study completedNCT01343082
What this trial is testing

DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 148
Early research (Phase 1)Study completedNCT01943721
What this trial is testing

The VISION5 Product in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Ocular HypertensionPrimary Open Angle Glaucoma
ForSight Vision5, Inc. 14
Testing effectiveness (Phase 2)Study completedNCT03896633
What this trial is testing

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

Who this might be right for
GlaucomaOpen Angle or Ocular Hypertension
Bausch & Lomb Incorporated 637
Large-scale testing (Phase 3)Study completedNCT00751049
What this trial is testing

Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom

Who this might be right for
Ocular HypertensionOpen Angle Glaucoma
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 294
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation